89bio, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q2 2025.

Location
San Francisco, CA
Fiscal year end
31 December
Latest financial report
08 Aug 2025

Quick Takeaways

  • 89bio, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q2 2025.
  • Headline metric: Return On Equity -87%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+138%</span>.
  • Most recent SEC facts end date: 31 Jul 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-07-31) highlights Return On Equity -86.9%, Return On Assets -75.9%, and Current Ratio 15.19x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

20.3/100

Weak Confidence medium

Return On Equity

-87%

Metric score 0.0/100

Return On Assets

-76%

Metric score 0.0/100

Financial Health

Current Ratio
15.19x
Debt to Equity
0.17x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

-87%

YoY: +138%

Industry median: -43% (n=675)

View history

Return On Assets

-76%

YoY: +134%

Industry median: -47% (n=673)

View history

Current Ratio

15.19x

YoY: +9.1%

Industry median: 3.39x (n=667)

View history

Debt-to-equity

0.17x

YoY: +35%

Industry median: 0.26x (n=530)

View history

NetIncomeLoss YoY

-158%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -87% +138%
Return On Assets -76% +134%

Financial Health

Metric Latest value YoY change
Current Ratio 15.19x +9.1%
Debt-to-equity 0.17x +35%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -158%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 148,308,250 +40%
Common Stock, Shares, Outstanding 148,304,875 +41%
Common Stock, Value, Issued $148,000 +41%
Weighted Average Number of Shares Outstanding, Basic 157,880,203 +58%
Weighted Average Number of Shares Outstanding, Diluted 157,880,203 +58%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $421,040,000 +168%
General and Administrative Expense $44,636,000 +31%
Operating Income (Loss) $465,676,000 -143%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $448,855,000 -163%
Income Tax Expense (Benefit) $1,351,000 -67%
Earnings Per Share, Basic -3 -88%
Earnings Per Share, Diluted -3 -88%
Cash and Cash Equivalents, at Carrying Value $129,076,000 -39%
Marketable Securities, Current $432,088,000 +35%
Cash, Cash Equivalents, and Short-term Investments $561,200,000 +5.6%
Assets, Current $601,520,000 +3.7%
Property, Plant and Equipment, Net $77,000 +185%
Operating Lease, Right-of-Use Asset $1,256,000 -35%
Other Assets, Noncurrent $632,000 +101%
Assets $603,485,000 +3.7%
Accounts Payable, Current $14,657,000 -16%
Employee-related Liabilities, Current $5,016,000 +34%
Accrued Liabilities, Current $24,170,000 +30%
Liabilities, Current $39,611,000 -4.9%
Operating Lease, Liability, Noncurrent $679,000 -54%
Other Liabilities, Noncurrent $5,306,000 +41%
Liabilities $81,752,000 +22%
Accumulated Other Comprehensive Income (Loss), Net of Tax $122,000
Retained Earnings (Accumulated Deficit) $1,007,290,000 -81%
Stockholders' Equity Attributable to Parent $521,733,000 +1.3%
Liabilities and Equity $603,485,000 +3.7%
Common Stock, Shares Authorized 200,000,000 0%
Common Stock, Shares, Issued 148,304,875 +41%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $129,076,000 -39%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $449,401,000 -157%
Operating Lease, Liability, Current $784,000 +3.3%
Unrecognized Tax Benefits $5,300,000
Share-based Payment Arrangement, Expense $24,998,000 +35%
Interest Expense $5,957,000 +67%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY